Peptide Storage & Shelf Life: How to Store BPC-157 and Other Research Peptides
Updated: Aug 28
Storage is one of the most consequential and most overlooked aspects of research peptide work. A peptide that arrives at ≥99% HPLC purity but is held incorrectly can degrade measurably before it is ever assayed. The investment in third-party testing, quality verification, and supplier evaluation can be undermined by a single afternoon of ambient exposure or one freeze-thaw cycle.
This guide covers what determines the stability of lyophilized research peptides in storage: temperature thresholds, light protection, freeze-thaw effects, expected shelf life across the Durham Peptides catalogue, visible indicators of degradation, and transport considerations.
For the foundational concept, see What Is Lyophilization? Why Every Research Peptide Is Freeze-Dried.
Two Physical Forms, Two Stability Profiles
Research peptides exist in two physical states, and their stability differs by an order of magnitude.
Lyophilized (freeze-dried) form. The dry powder as supplied. Lyophilization removes water under vacuum at low temperature, leaving a solid in which the molecular mobility that drives degradation reactions is severely restricted. Lyophilized peptides are stable for months to years under appropriate conditions.
Solution phase. Once a lyophilized peptide is dissolved in aqueous diluent, water becomes available as both a reactant and a mobility medium. Hydrolysis, deamidation, oxidation, and aggregation all proceed far faster than in the solid state. Stability drops from months to weeks.
The transition is irreversible. Material held in the solid state retains its stability profile; once dissolved, the faster degradation kinetics apply for the remainder of that material's life.
Lyophilized Storage Conditions
Refrigerated (2–8 °C). Suitable for most lyophilized peptides over a period of months. Durham Peptides ships under conditions consistent with refrigerated storage on arrival.
Frozen (−20 °C). Optimal for long-term holding. Lyophilized peptides at −20 °C remain stable for years rather than months. For extended timelines, frozen storage is the conservative choice.
Ultra-low (−80 °C). The reference standard for very long-term storage of high-value samples. Ultra-low freezers are uncommon outside institutional laboratories; −20 °C is the practical limit for most facilities.
Ambient. Not recommended for extended periods. Brief ambient exposure during transit or handling is tolerated without meaningful loss, but sustained ambient storage accelerates degradation substantially.
Why temperature dominates. Peptide degradation is a set of chemical reactions — bond hydrolysis, side-chain modification, fragment formation. Reaction rates roughly double for every 10 °C increase, a relationship described by the Arrhenius equation. A peptide stable for one year at −20 °C may hold six months at 4 °C, three months at ambient, and considerably less in warmer conditions.
Expected Shelf Life, Lyophilized
Approximate stability under appropriate storage across the Durham Peptides catalogue:
Across the current catalogue — BPC-157, TB-500, GHK-Cu, MOTS-c, Semaglutide, GLOW Blend, and Wolverine Stack — expected stability in lyophilized form is:
Refrigerated (2–8 °C): 12–18 months
Frozen (−20 °C): 24+ months
These are general guidance ranges, not expiration dates. Actual stability depends on storage conditions, manufacturing batch, and the chemistry of the specific sequence. For maximum shelf life, hold unopened vials frozen.
For BPC-157 specifically, see BPC-157 Storage Temperature and Shelf Life.
Solution-Phase Stability
Material in aqueous solution is governed by different constraints.
Refrigerated (2–8 °C) is the only appropriate condition for peptide solutions. Degradation continues at refrigerated temperature but proceeds slowly enough that solutions remain analytically useful for a period of weeks rather than months.
Frozen storage is not appropriate for aqueous peptide solutions. Ice crystal formation, solute concentration gradients during phase change, and pH shifts in the freezing solution all impose structural stress. Where a diluent contains benzyl alcohol, that component also undergoes phase changes that alter solution chemistry.
Ambient conditions accelerate hydrolysis and oxidation markedly and are not suitable for holding solutions.
Solutions held beyond a few weeks should be treated as analytically unreliable regardless of appearance. Where compound integrity is material to a result, freshly prepared solution from solid stock is the sound choice.
Light Protection
Some sequences are photosensitive, particularly under UV.
Photodegradation. Tryptophan, tyrosine, and methionine residues are susceptible to light-driven modification. Storage in clear containers under bright light accelerates this.
Practical protection. Most research peptide vials are amber or supplied in opaque outer packaging providing adequate protection. Holding the vial inside its outer packaging in a dark compartment adds margin. Direct sunlight and strong fluorescent exposure should be avoided.
Solutions in clear vials are more vulnerable than lyophilized powder in amber glass. Foil wrapping or a dark container adds protection where solution is held for any extended period.
Freeze-Thaw Cycling
For frozen material, repeated cycling causes more damage than continuous frozen storage.
Why cycling is damaging. Each cycle stresses the molecule through ice crystal formation, concentration gradients during thaw, and pH shift. The effect is cumulative across cycles.
Practical implication. For frozen stock needed across several months, a single thaw followed by refrigerated holding is preferable to repeated cycling. Alternatively, aliquot solid material into smaller portions before freezing so that each thaw consumes a complete aliquot.
Indicators of Degradation
Lyophilized material. Correctly lyophilized peptide is typically a uniform white solid, with some variation in density and particle size. Marked colour change (yellowing, browning), hard clumping, or visible moisture suggests degradation or a compromised seal.
Solution. Peptide solutions should be clear and free of visible particulate. Cloudiness, precipitation, or suspended particles indicate degradation or contamination.
Analytical drift. Where a compound is being used as an analytical reference, unexplained variance against a known standard can indicate degradation before any visual change is apparent. This is one reason quality begins with confirmed identity — see How to Verify Peptide Quality — and is preserved through storage.
Beyond the stability window. Lyophilized material past 18–24 months refrigerated should be assessed before use. Degraded material may retain partial integrity, but variability rises and reproducibility falls.
Transport and Transit
Supplier to facility. Most research peptides ship at ambient temperature in insulated packaging over 1–3 days. Lyophilized material tolerates this without meaningful loss; refrigerated shipping is unnecessary over short domestic distances. Durham Peptides ships standard ambient packaging within Canada.
Transfer between sites. Brief ambient transfer over a period of hours is acceptable for lyophilized material. Solutions require active cold management — cold packs and insulated containment.
International transit. Longer transit — weeks, for shipments originating in Asia or Europe — increases cumulative ambient exposure. This is one of several reasons Canadian-domestic supply, where transit is typically measured in days, is preferable.
Storage Workflow
On arrival. Inspect the vial for seal integrity and visible damage. Move to refrigerated storage (2–8 °C) promptly. Where holding beyond roughly three months is anticipated, transfer to −20 °C instead.
Inventory control. Record receipt date, batch or lot identifier, and storage location for each vial. Batch traceability is what allows an anomalous result to be tied back to a specific unit of material.
Long-term holding. Lyophilized material approaching the end of its refrigerated window can be moved to frozen storage to extend usable life. Move material before the window closes, not after.
End of life. Material past its stability window should be assessed rather than assumed usable. Where reproducibility matters, fresh stock is the sound choice.
Where Storage Most Often Goes Wrong
Freezing aqueous solutions. Causes freeze-thaw structural damage. Solutions belong at 2–8 °C.
Extended ambient exposure. Whether during handling or storage, sustained ambient conditions accelerate degradation. Return material to cold storage promptly.
Storing in a temperature-unstable zone. Compartments subject to frequent opening cycle through a wider temperature range than the main body of a cold storage unit. Use a stable interior location.
Repeated freeze-thaw cycles. Each cycle imposes cumulative stress. Plan for a single thaw per vial.
Untracked inventory. Without receipt dates and batch identifiers, the stability position of any given vial is unknowable.
Storing research material alongside unrelated items. Dedicated cold storage prevents cross-contamination and handling errors.
Skipping visual inspection. Inspection is the first quality control step before any analytical use.
Why Storage Matters
Storage sits downstream of quality. Material that began at ≥99% HPLC purity against a verified Janoshik COA can degrade through poor handling to substantially lower effective purity. Supplier evaluation, third-party COA verification, and protocol design are all undermined if material degrades before it is used.
Storage is the bridge between verified quality at receipt and confirmed quality at the point of analysis.
Frequently Asked Questions
Do research peptides need refrigeration? Yes. Lyophilized peptides should be held at 2–8 °C for moderate-term storage and −20 °C for long-term storage. Aqueous solutions require refrigeration.
How long do lyophilized peptides last? Approximately 12–18 months refrigerated (2–8 °C) and 24+ months frozen (−20 °C) for most research peptides.
How stable are peptides in solution? Substantially less stable than in the solid state — weeks rather than months, and only under refrigeration. Degradation continues throughout.
Can peptide solutions be frozen? No. Freeze-thaw cycling damages peptide structure, and benzyl-alcohol-containing diluents undergo phase changes that alter solution chemistry.
What happens with ambient exposure? Brief exposure over hours typically causes no major degradation. Sustained ambient storage over days to weeks accelerates degradation significantly.
What freezer temperature is appropriate? Standard freezers operate at approximately −18 °C to −20 °C, which is appropriate for long-term lyophilized storage. Ultra-low (−80 °C) offers additional margin but is uncommon outside institutional settings.
Does light affect stored peptides? Some sequences degrade under light exposure, particularly UV. Most vials are amber or supplied in opaque packaging. Dark storage adds protection.
How long do peptides survive shipping? Lyophilized material tolerates ambient temperature over 1–3 days of transit without significant degradation. Longer transit increases cumulative exposure; domestic supply minimises it.
Can material past its stability window still be used? It may retain partial integrity, but variability increases. Where consistent quality matters, fresh material is preferred. Visual inspection and analytical comparison against a known standard are the available checks.
What is the difference between solid and solution stability? Lyophilized peptides are stable for months to years under appropriate cold storage. Solutions are stable for weeks, refrigerated only. The transition from solid to solution is one-way.
Final Thoughts
Proper storage preserves the quality investment made when COAs were verified and suppliers selected. The principles are straightforward: lyophilized material refrigerated, or frozen for long-term holding; solutions refrigerated only and treated as short-lived; protected from light; protected from temperature cycling; tracked by batch and receipt date.
For related concepts, see What Is Lyophilization? and Peptide Half-Life Explained.
Browse the complete Durham Peptides Canadian-domestic catalogue at durhampeptides.ca/category/all-products. For all Janoshik-verified COAs, see durhampeptides.ca/lab-results.
Selected References
Manning MC, Chou DK, Murphy BM, Payne RW, Katayama DS. Stability of Protein Pharmaceuticals: An Update. Pharmaceutical Research. 2010;27(4):544–575. https://pubmed.ncbi.nlm.nih.gov/20143256/
Jorgensen L, Hostrup S, Moeller EH, Grohganz H. Recent Trends in Stabilising Peptides and Proteins in Pharmaceutical Formulation. Expert Opinion on Drug Delivery. 2009;6(11):1219–1230. https://pubmed.ncbi.nlm.nih.gov/19852680/
Lai MC, Topp EM. Solid-State Chemical Stability of Proteins and Peptides. Journal of Pharmaceutical Sciences. 1999;88(5):489–500. https://pubmed.ncbi.nlm.nih.gov/10229640/
Pikal MJ, Rigsbee D, Roy ML, et al. Solid State Chemistry of Proteins: II. Journal of Pharmaceutical Sciences. 2008;97(12):5106–5121. https://pubmed.ncbi.nlm.nih.gov/18351639/
Wang W. Lyophilization and Development of Solid Protein Pharmaceuticals. International Journal of Pharmaceutics. 2000;203(1-2):1–60. https://pubmed.ncbi.nlm.nih.gov/10967427/
United States Pharmacopeia. USP General Chapter 1191, Stability Considerations in Dispensing Practice.
All products sold by Durham Peptides are for research and laboratory use only. They are not intended for human or animal consumption, diagnosis, treatment, cure, or prevention of any disease. This article is informational and does not constitute medical advice.